Mimura et al. [42] reported that elevated expression of tumor cell MHC Class I chain-related A (MICA), MHC Class I chain-related B (MICB), and several UL-16-binding proteins (ULBPs), which are receptors for the NK cell-activating receptor, NKG2D, was associated with improved survival outcomes. This evidence concerns the gene MICA and neoplasm.